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Abstract Previous studies have indicated that the early
steps in the isoprenoid/cholesterol biosynthetic pathway
occur in peroxisomes. However, the role of peroxisomes
in cholesterol biosynthesis has recently been questioned
in several reports concluding that three of the peroxi-
somal cholesterol biosynthetic enzymes, namely mevalo-
nate kinase, phosphomevalonate kinase, and
mevalonate diphosphate decarboxylase, do not localize
to peroxisomes in human cells even though they contain
consensus peroxisomal targeting signals. We re-investi-
gated the subcellular localization of the cholesterol bio-
synthetic enzymes of the pre-squalene segment in
human cells by using new stable isotopic techniques and
data computations with isotopomer spectral analysis, in
combination with immunoXuorescence and cell permea-
bilization techniques. Our present Wndings clearly show
and conWrm previous studies that the pre-squalene seg-
ment of the cholesterol biosynthetic pathway is localized
to peroxisomes. In addition, our data are consistent with
the hypothesis that acetyl-CoA derived from peroxi-
somal -oxidation of very long-chain fatty acids and
medium-chain dicarboxylic acids is preferentially chan-
neled to cholesterol synthesis inside the peroxisomes
without mixing with the cytosolic acetyl-CoA pool.
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Peroxisomes · Mass isotopomer distribution · HepG2
Abbreviations
AOX Acyl-CoA oxidase
FPP Farnesyl diphosphate
GFP Green Xuorescent protein
HMGCR HMG-CoA reductase
IDI1 Isopentenyl diphosphate isomerase 1
ISA Isotopomer spectral analysis
MID Mass isotopomer distributions
MPD Mevalonate diphosphate decarboxylase
MVK Mevalonate kinase
PEX Peroxin
PMP Peroxisomal membrane protein
PMVK Phosphomevalonate kinase
PP Diphosphate
PTS Peroxisomal targeting signal
Introduction
Peroxisomes are ubiquitous and highly versatile organ-
elles of eukaryotic cells whose enzymes participate in
various metabolic pathways including: (1) -oxidation
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274 Histochem Cell Biol (2007) 127:273–290of a speciWc set of lipids which cannot be processed by
mitochondria (very long-chain fatty acids, long-chain
dicarboxylic acids, eicosanoids, and bile acid intermedi-
ates), (2) biosynthesis of cholesterol, isoprenoids, and
ether-phospholipids (plasmalogens), and (3) reactive
oxygen species metabolism (Mannaerts et al. 2000;
Wanders 2004; Kovacs et al. 2002; Schrader and Fahimi
2004). Two peroxisomal targeting signals (PTSs), PTS1
and PTS2, account for the transport of most enzymes
involved in these metabolic pathways into the peroxi-
some matrix (Subramani 1993). PTS1, the major target-
ing signal, is a carboxyl-terminal tripeptide with the
consensus sequence (S/C/A)(K/R/H)(L/M) and targets
proteins to the peroxisome in all eukaryotic organisms
examined, from yeast to man. PTS1-dependent trans-
port is mediated by a shuttling receptor, the peroxin
Pex5p, which recognizes the PTS1 tripeptide in the
cytoplasm and mediates the import of PTS1-containing
proteins into the peroxisome (Dammai and Subramani
2001). Recent analysis of sequence variability in the
PTS1 motif revealed that, in addition to the known
C-terminal tripeptide, at least nine residues directly
upstream are important for signal recognition in the
PTS1-Pex5p receptor complex (Neuberger et al. 2003a).
The importance of speciWc residues near the C-terminus
appears to be particularly important if the C-terminal
tripeptide deviates from the conservative consensus
PTS1 (Lametschwandtner et al. 1998). A small subset of
peroxisomal matrix proteins is targeted by PTS2, which
consists of a degenerate nine-residue signal located
internally or near the amino terminus. The consensus
PTS2 has the sequence—(R/K)(L/V/I)X5(H/Q)(L/
A)—(Rachubinski and Subramani 1995). Some PTS2
proteins have the PTS2 removed by a peroxisomal pep-
tidase upon entering the peroxisomal lumen (Subra-
mani 1993). The import of PTS2 proteins into
peroxisomes is mediated by the hydrophilic cytoplasmic
receptor Pex7p, which is also dependent on the long
isoform of Pex5p (Mukai et al. 2002; Ghys et al. 2002).
Isoprenoids and isoprenoid compounds play vital
roles in all living systems, e.g. in the structure of cells,
in electron transport, in glycoprotein synthesis, in cell
to cell signaling, in transfer RNAs, in the structure of
organisms, and in the interactions between organisms
(Goldstein and Brown 1990). The enzymes that pro-
duce cholesterol and other isoprenoids are distributed
in diVerent subcellular compartments (Kovacs et al.
2002). The prevailing view has been that cholesterol
biosynthetic reactions occur in the cytoplasm and
endoplasmic reticulum (ER). However, numerous
studies have indicated that the early steps in the iso-
prenoid/cholesterol biosynthetic pathway occur in per-
oxisomes (Keller et al. 1985, 1986; Stamellos et al.
1992; Biardi et al. 1994; Krisans et al. 1994; Biardi and
Krisans 1996; Chambliss et al. 1996; Paton et al. 1997;
Olivier et al. 1999, 2000; Gupta et al. 1999; Kovacs
et al. 2001). In addition, with the exception of
3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
reductase, the enzymes contain functional PTSs
(Table 1). Furthermore, the enzymes catalyzing the
conversion of mevalonate to farnesyl diphosphate
(FPP) appear to be exclusively peroxisomal. Due to
these facts, a new model for the compartmentation of
the cholesterol biosynthetic pathway has been pre-
sented (Kovacs et al. 2002).
However, the role of peroxisomes in cholesterol bio-
synthesis has recently been questioned in several
reports concluding that three of the peroxisomal cho-
lesterol biosynthetic enzymes, namely mevalonate
kinase (MVK), phosphomevalonate kinase (PMVK),
and mevalonate diphosphate decarboxylase (MPD),
do not localize to peroxisomes in human cells even
though they contain consensus PTSs (Hogenboom
et al. 2004a, b, c).
Since the data from Hogenboom et al. (2004a, b, c)
are conXicting with the concept of a peroxisomal seg-
ment of cholesterol biosynthesis and our previous work
was done mainly using rat liver and Chinese hamster
ovary (CHO) cells, we decided to re-investigate the
subcellular localization of the “pre-squalene” choles-
terol biosynthetic enzymes in human cells. By using new
stable isotopic techniques and data computations with
isotopomer spectral analysis (ISA), in combination with
immunoXuorescence and selective permeabilization
techniques, we clearly conWrm our previous studies
obtained in rats and CHO cells. In addition, we provide
new evidence compatible with the presence of the pre-
squalene part of sterol synthesis in peroxisomes. Fur-
thermore, we show that acetyl-CoA derived from per-
oxisomal -oxidation of very long-chain fatty acids and
medium-chain dicarboxylic acids is preferentially chan-
neled to cholesterol synthesis inside the peroxisomes
without mixing with the cytoplasmic acetyl-CoA pool.
Materials and methods
Antibodies
The following antibodies against cholesterol biosyn-
thetic enzymes were used: rabbit polyclonal anti-
(HMG-CoA) reductase (a gift of P. Edwards, Univer-
sity of California at Los Angeles), anti-MVK (Biardi
et al. 1994), anti-(isopentenyl diphosphate dimethylal-
lyl diphosphate) (IPP) isomerase 1 (Paton et al. 1997;
Kovacs et al. 2004a), and anti-FPP synthase (Krisans123
Histochem Cell Biol (2007) 127:273–290 275et al. 1994); mouse monoclonal anti-(HMG-CoA)
reductase (a gift of M.S. Brown and J.L. Goldstein,
University of Texas Southwestern Medical Center,
USA). Antibodies against the following intracellular
compartments were used: (1) Peroxisomes: rabbit poly-
clonal anti-guinea pig catalase, anti-rat acyl-CoA oxi-
dase (AOX) and anti-rat PMP70 (peroxisomal
membrane protein 70) (Beier et al. 1988; Lüers et al.
1993) (a gift of A. Völkl, University of Heidelberg);
sheep polyclonal anti-human catalase (The Binding
Site, Birmingham, UK); (2) mitochondria: rabbit poly-
clonal anti-cytochrome c (Santa Cruz Biotechnology,
Santa Cruz, CA); (3) lysosomes and endosomes: mouse
monoclonal anti-human Limp-1 (CD63), anti-Rab5
and anti-(early endosome antigen 1) (EEA1) (BD Bio-
sciences-Pharmingen, San Diego, CA); mouse mono-
clonal anti-human Lamp-2 (lysosomal associated
membrane protein-2) (Research Diagnostics, Flanders,
NJ). The monoclonal mouse antibody against the myc
epitope was obtained from Invitrogen (Carlsbad, CA,
USA). Species-speciWc anti-IgG antibodies conjugated
to Alexa 488 (A-11008, A-11001), 594 (A-11012,
A-11005), and 647 (A-21244, A-21235) were obtained
from Molecular Probes (Eugene, OR, USA). The
Texas Red dye-conjugated donkey anti-sheep IgG
(#713-075-147) was obtained from Jackson Immuno-
Research (West Grove, PA, USA).
Cell culture
HepG2 cells (Aden et al. 1979), derived from a human
hepatoblastoma, were obtained from the American
Tissue Culture Collections (Rockville, MD) and grown
in Dulbecco’s ModiWed Eagle Medium:Ham’s F-12
(1:1, v/v) medium supplemented with 10% (v/v) fetal
calf serum (FCS). The CHO cell line, CHO-K1, and
the peroxisome-deWcient mutant CHO lines (ZR-78,
ZR-82, and ZR-87), which are all deWcient in Pex2p,
were obtained from Dr. Raphael A. Zoeller (Boston
University School of Medicine, Boston, MA) and
grown in Ham’s F-12 medium supplemented with 10%
(v/v) fetal calf serum. PEX2-transfected CHO-K1/
pPEX2, ZR-78/pPEX2, ZR-82/pPEX2 and ZR-87/
pPEX2 cells were maintained in the same medium con-
taining 500 g/ml G418. Cells were cultivated at 37°C
in a humidiWed atmosphere of 5% CO2 and 95% air.
Cells were grown on collagenized coverslips in media
containing 5% lipoprotein-deWcient serum (Intracel,
Frederick, MD) for 24 h prior to immunoXuorescence
studies using antibodies against endogenous cholesterol
Table 1 Sequences of func-
tional PTS motifs in choles-
terol biosynthetic enzymes
Protein name Sequence of carboxy 
terminus including PTS1 motif
Organism Accession 
number
Acetoacetyl-CoA thiolase GGGASAMLIQKL
GGGASALLIEKL
GGGASAVLIEKL
Hs
Mm
Rn
D90228
BC024763
D13921
Phosphomevalonate kinase LENLIEFIRSRL
LEHLLGFIQAKL
NLLEFIHAKLQR
Hs
Mm
Rn
BC007694
AK003607
BC086349
Isopentenyl-PP isomerase NQFVDHEKIYRM
SPFVDHEKIHRL
SPFVDHEKIHRM
Hs
Mm
Rn
AF271720
BC004801
AF003835
PTS2 sequences
HMG-CoA synthase SVKTNLMQL
SVKSNLMQL
SVKSNLMQL
Hs
Mm
Rn
BC000297
BC029693
X52625
Mevalonate kinase KVILHGEHA
KVILHGEHA
KVILHGEHA
Hs
Mm
Rn
M88468
BC005606
M29472
Mevalonate-PP decarboxylase SVTLHQDQL
SVTLHQDQL
SVTLHQDQL
Hs
Mm
Rn
U49260
AJ309922
U53706
Isopentenyl-PP isomerase HLDKQQVQL
HLDEKQVQL
NLDEKQVQL
Hs
Mm
Rn
AF271720
BC004801
AF003835
Farnesyl-PP synthase NSDVYAQE
KLDAYNQE
KLDVHNQE
Hs
Mm
Rn
J05262
BC048497
M34477
Consensus PTS1 (S/C/A)(K/R/H)(L/M)
Consensus PTS2 (R/K)(L/V/I)X5(H/Q)(L/A)
Hs Homo sapiens, Rn Rattus 
norvegicus, Mm Mus muscu-
lus123
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MVK, IDI1, and FPP synthase].
Vector construction
The construction of expression vectors for full-length
acetoacetyl-CoA thiolase (ACAT1) containing a myc
epitope tag between the mitochondrial and PTSs
(Olivier et al. 2000), pEGFP-PMVK and pEGFP-
PMVKPTS (Olivier et al. 1999) has been described
before. The expression vector pDsRed2-Peroxi, which
encodes a fusion of Discosoma sp. red Xuorescent pro-
tein and the PTS1 “SKL”, was purchased from Clon-
tech. The vector expressing DsRed2 ending in QKL
and EKL was generated by ligating the appropriate
insert into the Not I and Pst I digested pDsRed2-Per-
oxi vector. The insert was generated using the primers
5-caggactcctccctgcagga and 5-cgcggccgctacagcttctgct-
tgta (for pDsRed2-QKL) and pDsRed2-Peroxi as the
PCR template. PCR products were ligated into pCR4-
TOPO vector (Invitrogen, Carlsbad, CA) and digested
with Not I and Pst I. Subcloning and reading frame
were veriWed by both restriction digest and DNA
sequencing.
Transfection and immunoXuorescence
Transient transfections were performed using the
Lipofectamine 2000 reagent (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions.
Cells grown on collagen-coated glass coverslips were
Wxed with 4% paraformaldehyde in PBS, pH 7.4, per-
meabilized with 0.2% Triton X-100 and incubated with
primary and secondary antibodies as described (Kov-
acs et al. 2004b).
Fixed cells labeled with antibodies and/or Xuorescent
proteins were optically sectioned into z-stacks, with the
pinhole set to 1 Airy unit. Fluorescent dyes were
imaged sequentially in frame interlace mode to elimi-
nate cross-talk between the channels. Fluorescence was
visualized using a DM-IRBE confocal microscope
(Leica, Wetzlar, Germany) and images were processed
using TCS-NT software (Leica). A representative opti-
cal section is presented for each data set.
Cell permeabilization with digitonin
Cell permeabilization experiments were performed as
described by Biardi and Krisans (1996) with a few
modiWcations. HepG2 cells were seeded at a density
of 3.0 £ 106 on 100-mm plates and grown to 50% con-
Xuence. The cells were washed with PBS and trans-
ferred to media containing 5% lipoprotein-deWcient
serum (Intracel, Frederick, MD) for 72 h prior to the
experiment. On the day of the experiment, the cells
were washed twice with ice-cold KH buVer (50 mM
HEPES, 110 mM KOAc, pH 7.2), transferred to ice
and incubated in KHM buVer (20 mM HEPES,
110 mM KOAc, 2 mM MgOAc, pH 7.2) containing
various concentrations of digitonin (0, 20, 50, 150,
500, and 1,000 g/ml). After 5 min, the buVer was col-
lected as supernatant fractions and kept on ice. The
cells were washed twice with ice-cold KH buVer and
subsequently incubated in KH buVer containing
1,000 g/ml digitonin for 30 min. These latter frac-
tions were referred to as pellet fractions. The activi-
ties of phosphoglucose isomerase (PGI), a cytosolic
marker enzyme, and catalase, a peroxisomal marker
enzyme, were measured as described previously
(Kovacs et al. 2001).
[13C]Acetyl-CoA enrichment for sterol synthesis
[U-13C12]Dodecanedioic acid was obtained from
Isotec (Miamisburg, OH). [1,2,3,4-13C4]Docosanoic
acid was synthesized from stearyl bromide and
[U-13C4]acetoacetate ethyl ester (Zhang et al. 1994).
The purity of the synthesized compounds was veriWed
by gas chromatography-mass spectrometry (GC-MS)
and NMR.
Docosanoic acid was dissolved either in ethanol or
in 2.8 mM NaOH containing 10% fatty acid-free
bovine serum albumin (faf-BSA). Dodecanedioic acid
was dissolved in 1 M NaOH and added to the media
containing 5% lipoprotein-deWcient serum. HepG2,
CHO-K1, and peroxisome-deWcient CHO cells were
incubated with either 0.1 mM and 0.2 mM unlabeled
and [1,2,3,4-13C4]docosanoate or 1, 2, and 3 mM unla-
beled and [U-13C12]dodecanedioate for 24, 48, and
72 h. Media were changed every day. Cells were
washed once with ice-cold PBS containing 2 mg/ml faf-
BSA and twice with PBS prior to collection. Lipid
extracts were saponiWed in KOH-ethanol before
extraction of the sterols with petroleum ether. The
aqueous phase was acidiWed, and fatty acids were
extracted with petroleum ether. Sterols and fatty acids
were derivatized with pentaXuorobenzoyl chloride and
pentaXuorobenzoyl bromide, respectively. The deriva-
tives were assayed by ammonia negative chemical ioni-
zation GC-MS to determine the mass isotopomer
distribution (MID) of the compounds (Bederman et al.
2004a, b; Kelleher and Masterson 1992; Lindenthal
et al. 2002). All analyses were run with double or triple
injection. Mass isotopomers are designated as M, M1,
M2,..., Mi, where i is the number of mass units above
that of the unlabeled isotopomers M.123
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Mass isotopomer spectral analysis of cholesterol 
synthesis
Until the recent demonstration of peroxisomal -oxi-
dation contributing to acetyl-CoA for malonyl-CoA
synthesis, peroxisomal -oxidation has not been con-
sidered as a substantial source of acetyl-CoA (Reszko
et al. 2004). However, little information is available on
the fate of peroxisomal acetyl-CoA. It has been shown
that peroxisomal enzymes can convert acetyl-CoA
(presumably derived from very long-chain fatty acid
oxidation) to FPP via HMG-CoA and mevalonate
(Fig. 1) (Weinhofer et al. 2006; for review see Kovacs
et al. 2002). FPP leaves the peroxisome, and is con-
verted to cholesterol in the endoplasmic reticulum
(Stamellos et al. 1993). In parallel, cytosolic acetoace-
tyl-CoA thiolase and HMG-CoA synthase form HMG-
CoA which, in the ER, is converted to mevalonate
(Fig. 1). The latter diVuses or is transferred into the
peroxisomes and mixes with locally made mevalonate.
A related question is whether acetyl-CoA, formed by
peroxisomal -oxidation of very long-chain fatty acids
is (1) directly channeled to cholesterol synthesis inside
the peroxisomes, or (2) mixes with cytosolic acetyl-
CoA transferred from mitochondria via citrate before
being used for fatty acid and cholesterol synthesis. At
least in the liver, part of the acetyl groups derived from
peroxisomal oxidation can be released as free acetate
(Bian et al. 2005); however, the mechanism of the
transfer of peroxisomal acetyl-CoA to the cytosol
needs to be further studied.
To resolve the issue of the existence of two parallel
pathways leading to mevalonate and the two theories
on the compartmentation of cholesterol synthesis, we
used new stable isotopic techniques and data computa-
tions with ISA (Bederman et al. 2004a, b; Kelleher and
Masterson 1992; Lindenthal et al. 2002). We tested
whether acetyl-CoA derived from peroxisomal long-
chain fatty acid oxidation (1) is directly channeled into
the peroxisomal reactions linking acetyl-CoA to FPP
(Pathway 1; Fig. 1), and/or (2) is partially released from
the peroxisomes before it is used in the reactions form-
ing extra-peroxisomal mevalonate (Pathway 2; Fig. 1).
Experiments with (1) carbon-labeled substrates which
label exclusively mitochondrial acetyl-CoA, and (2)
deuterated or tritiated water which yield a measure-
ment of total fatty acid and cholesterol synthesis,
reveal an equal percent contribution of mitochondrial
acetyl-CoA to fatty acid and cholesterol synthesis.
Thus, tracers that label exclusively or predominantly
acetyl-CoA cannot be used to test for a peroxisomal
pathway of cholesterol synthesis. However, very long-
chain fatty acids and medium-chain dicarboxylates
undergo initial -oxidation in peroxisomes (Mannaerts
et al. 2000; Leighton et al. 1989; Bian et al. 2005), and
such fatty acids, labeled on the Wrst carbons, generate
highly labeled acetyl-CoA in peroxisomes. We com-
pared the MIDs of fatty acids and sterols in CHO-K1,
peroxisome-deWcient CHO (ZR-82, ZR-87), and
HepG2 cells incubated with various concentrations of
[1,2,3,4-13C4]docosanoate or [U-
13C12]dodecanedioate
for 24, 48, and 72 h. The MIDs of fatty acids and sterols
were subjected to ISA to estimate the fractional contri-
bution of the labeled precursor to acetyl-CoA.
The MIDs of lathosterol and cholesterol isolated
from CHO-K1 cells incubated with 0.1 mM unlabeled
docosanoate (C22:0) or [1,2,3,4-13C4]docosanoate are
shown in Table 2. Lathosterol is the analyte of choice,
because, unlike cholesterol, its pool is small and turns
over rapidly (Lindenthal et al. 2002). It is clear, that in
the presence of unlabeled docosanoate, few lathosterol
molecules contained one or two 13C atoms. However,
in the presence of [1,2,3,4-13C4]docosanoate, lathos-
terol molecules contained up to Wve 13C atoms, which
reXects substantial labeling of acetyl-CoA used for ste-
rol synthesis. In contrast, fatty acids (myristate, palmi-
tate, stearate, and oleate) were not labeled from
[1,2,3,4-13C4]docosanoate (data not shown), indicating
that acetyl-CoA derived from peroxisomal -oxidation
was not released from peroxisomes and mixing with
cytosolic acetyl-CoA transferred from mitochondria.
The above data obtained with [1,2,3,4-13C4]docosa-
noate were conWrmed by data from experiments with
[U-13C12]dodecanedioate. The latter also generates
highly labeled acetyl-CoA in peroxisomes. As controls,
we incubated the cells with 2 mM [1,2-13C2]acetate and
25 mM [U-13C6]glucose, which forms mitochondrial
[U-13C2]acetyl-CoA. The labeling ratio (acetyl of ster-
ols)/(acetyl of fatty acids) was 1.04 + 0.09 (n = 6) for
[U-13C6]glucose. In contrast, in the presence of 2 mM
[U-13C12]dodecanedioate for 72 h, the labeling ratio
was much greater than 1 (i.e., 1.72 in CHO and 1.30 in
HepG2 cells), revealing that acetyl-CoA generated by
peroxisomal -oxidation is channeled directly to sterol
synthesis inside the peroxisomes. Fractional synthesis
of fatty acids and sterols varied from 23 to 95%. How-
ever, the elevated sterol to fatty acid ratio for acetyl-
CoA enrichment was maintained under all conditions
for [U-13C12]dodecanedioate compared to [U-
13C6]glu-
cose. In accordance with the data from Bederman et al.
(2004a) obtained in perfused rat livers, MID analysis
revealed labeling of both fatty acids and sterols from
the same [1,2-13C2]acetyl-CoA pool. Furthermore, the
labeling of sterols and fatty acids was barely detectable123
278 Histochem Cell Biol (2007) 127:273–290Fig. 1 Current view of the subcellular localization of cholesterol
biosynthesis in mammalian cells and proposed pathways of ace-
tyl-CoA utilization. Peroxisomal enzymes can convert acetyl-
CoA, which is presumably derived from very long-chain fatty acid
oxidation, to farnesyl diphosphate via HMG-CoA and mevalo-
nate (Pathway 1). Reactions between mevalonate and farnesyl
diphosphate are assumed to be almost exclusively peroxisomal
and functional peroxisomal targeting signals have been identiWed
in all of those enzymes. FPP leaves the peroxisomes and is con-
verted to cholesterol in the endoplasmic reticulum (ER). In par-
allel, cytosolic acetyl-CoA is used by cytosolic acetoacetyl-CoA
thiolase and HMG-CoA synthase to form HMG-CoA, which is
converted to mevalonate in the ER (Pathway 2). The latter diVus-
es into the peroxisomes and mixes with locally made mevalonate.
In the liver, part of the acetyl groups derived from peroxisomal
oxidation are released as free acetate; however, the mechanism of
the transfer of peroxisomal acetyl-CoA to the cytosol needs to be
further studied. Isotopomer spectral analysis of fatty acids and
sterols suggests that acetyl-CoA, formed by peroxisomal -oxida-
tion of very long-chain fatty acids and medium-chain dicarboxylic
acids is directly channeled to cholesterol synthesis inside the per-
oxisomes (Pathway 1) without mixing with cytosolic acetyl-CoA
transferred from mitochondria before being used for fatty acid
and cholesterol synthesis (Pathway 2)
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Table 2 Mass isotopomer distribution of sterols in CHO-K1 cells incubated with docosanoate
CHO cells were cultured with either 0.1 mM unlabeled docosanoate (M DOC) or [1,2,3,4-13 C4]docosanoate (M4 DOC) for 72 h. The
mass isotopomer distribution of sterol is expressed as mol% fractions of molecule containing 0–5 13 C-atoms (M–M5). The presence of
M1–M4 isotopomers in the sterols from unlabeled cells reXects the natural 13 C-enrichment of the sterol derivatives (sterol
molecule + pentaXuorobenzoyl group)
Sterol assayed Substrate Mass isotopomer distribution (mol% fractions)
M M1 M2 M3 M4 M5
Cholesterol M DOC 67.96 25.78 5.32 0.79 0.15
M4 DOC 62.92 25.68 7.67 2.50 1.24
Lathosterol M DOC 67.86 27.22 4.18 0.74
M4 DOC 38.78 30.11 21.71 9.39 9.64 5.46123
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with precision in the peroxisome-deWcient cells ZR-82
and ZR-87. This is consistent with the disruption of the
peroxisomal -oxidation pathway due to mistargeting
and degradation of peroxisomal matrix enzymes in the
cytoplasm in those cells. Our data are suggestive for
the localization of part of sterol synthesis in CHO and
HepG2 cells in peroxisomes.
ImmunoXuorescence studies show that pre-squalene 
cholesterol biosynthetic enzymes are peroxisomal
Acetoacetyl-CoA thiolase
The formation of acetoacetyl-CoA is the Wrst step in
cholesterol and ketone body synthesis. Acetoacetyl-
CoA thiolase or acetyl-CoA acetyltransferase (ACAT)
activity is found in the cytosol, mitochondria, and per-
oxisomes of mammalian cells. Olivier et al. (2000) pro-
vided evidence for a PTS1 in mitochondrial
acetoacetyl-CoA thiolase (ACAT1) and suggested that
mitochondrial ACAT1 could be targeted under certain
circumstances to peroxisomes via its C-terminal QKL
(human) or EKL (mouse, rat).
To investigate the targeting of ACAT1, HepG2 cells
were transfected with the expression vector for full-
length rat ACAT1 containing a myc epitope tag
between the mitochondrial and PTSs as described
before (Olivier et al. 2000). Thereafter, they were pro-
cessed for double immunoXuorescence labeling using
antibodies against the myc epitope, the peroxisomal
markers AOX or peroxisomal membrane protein 70
(PMP70), as well as the mitochondrial marker cyto-
chrome c (Fig. 2a–c). The full-length ACAT1 dis-
played a mitochondrial distribution pattern in HepG2
cells (Fig. 2a, c) that was completely superimposable
over that for cytochrome c (data not shown). No co-
localization with the punctate peroxisomal pattern for
AOX (Fig. 2b, c) or PMP70 (data not shown) was
observed. We also co-transfected the expression vector
for full-length ACAT1 with pDsRed2-Peroxi (a mam-
malian expression vector that encodes a fusion of Dis-
cosoma sp. red Xuorescent protein and the PTS1—
SKL) into HepG2 cells. HepG2 cells were analyzed by
direct Xuorescence and immunostaining with antibod-
ies against myc and cytochrome c (Fig. 2d–f). Again,
the immunoXuorescence pattern obtained for ACAT1
was completely superimposable over that for cyto-
chrome c and did not overlap with the Xuorescent
punctate pattern of peroxisomes (Fig. 2f).
Our data suggest that the mitochondrial targeting
sequence overrules the PTS1 and that it is unlikely that
full-length mitochondrial ACAT1 is targeted to peroxi-
somes. Similarly, experimental evidence showed that
the PTS1 signal is lower in hierarchy compared with
N-terminal signals such as the mitochondrial targeting
signal if they are present in the same protein (Neuber-
ger et al. 2003b). Most probably, the binding of mito-
chondrial transport receptors to the N-terminus leads
to an immediate mitochondrial import of the nascent
polypeptide prior to binding of peroxisomal import
receptors to its C-terminal PTS1. To investigate if the
C-terminal tripeptide QKL might be functional as
PTS1 signal, a DsRed-fusion protein containing this C-
terminal peptide was expressed in HepG2 cells
(Fig. 2g–i). In a functional PTS1 signal, the tripeptide
SKL or conserved variants thereof would be suYcient
for peroxisomal protein import in several species
(Gould et al. 1990). DsRed ending in QKL, the C-ter-
minus of human ACAT1, showed a punctate distribu-
tion (Fig. 2g) which was superimposable onto the
pattern for the peroxisomal marker enzyme AOX
(Fig. 2h) (for overlay, see Fig. 2i). Analysis of the car-
boxy-terminal 12 residues of human ACAT1 with a
newly developed PTS1 prediction algorithm (Neuber-
ger et al. 2003b) assigned human ACAT1 as probable
PTS1 signal-containing protein and supported our
immunoXuorescence data.
Since our mass ISA data and other biochemical
experiments demonstrate peroxisomal acetoacetyl-
CoA formation (Thompson and Krisans 1990; Hovik
et al. 1991), either the distribution of ACAT1 between
peroxisomes and mitochondria is regulated by the vari-
able usage of alternative transcription or translation
initiation sites or another enzyme is involved in the
acetyl-CoA condensation reaction in peroxisomes.
Indeed, Antonenkov et al. (2000) puriWed a short chain
speciWc thiolase from rat liver peroxisomes that is
diVerent from the thiolases involved in the breakdown
of straight chain and 2-methyl-branched 3-oxoacyl-
CoAs (thiolase A and B and SCPx) and that also
appears to be distinct from ACAT1 and cytosolic ace-
toacetyl-CoA thiolase (ACAT2). Targeting to the per-
oxisomal matrix could also happen by “piggybacking”
of a thiolase (e.g., ACAT2) with another PTS contain-
ing protein.
Dual localization of HMG-CoA reductase
To verify the subcellular localization of HMGCR in
human cells, we examined the immunoXuorescence
pattern obtained with a monoclonal and a polyclonal
HMGCR antibody. HepG2 cells were cultured in
medium with lipoprotein-deWcient serum (LPDS) and
subsequently subjected to double-immunoXuorescence
labeling using antibodies against HMGCR (Fig. 3b, e)123
280 Histochem Cell Biol (2007) 127:273–290and the peroxisomal markers catalase (data not shown)
or PMP70 (Fig. 3a, d). The immunoXuorescence pat-
tern obtained for HMGCR was consistent with ER
labeling in all cells. However, in addition to an ER
labeling pattern, a number of cells exhibited an unam-
biguous punctate pattern, which was directly superim-
posable over that for PMP70 (Fig. 3c, f) and catalase
(data not shown). These results indicate that in human
cells HMGCR is localized both to the ER and peroxi-
somes. Although probably all cells contain to some
degree HMGCR in peroxisomes, peroxisomal
HMGCR staining will be masked in most cells by the
strong ER labeling, leading to an underestimation.
Keller et al. (1986) showed that less than 5% of the
total HMGCR activity is located in the peroxisomes of
rat liver under control conditions compared with
20–30% of the HMGCR activity detected in peroxi-
somes of cholestyramine-treated animals. Since peroxi-
somal HMGCR seems to be encoded by the same gene
as the ER enzyme (Breitling and Krisans 2002), the
Fig. 2 The mitochondrial acetyl-CoA acetyltransferase
(ACAT1) contains both an amino-terminal mitochondrial target-
ing signal and a carboxy-terminal PTS1. a–c HepG2 cells were
transfected with full-length rat ACAT1 containing a myc epitope
and processed for immunoXuorescence microscopy with antibod-
ies against myc (a), the peroxisomal marker acyl-CoA oxidase
(AOX) (b), and the mitochondrial marker cytochrome c. Full-
length rat ACAT1 displayed a mitochondrial distribution in
HepG2 cells that was completely superimposable over that for
cytochrome c (data not shown). Full-length ACAT1 was not
found to co-localize with the punctate peroxisomal pattern for
AOX (c). Though a few yellow punctate structures in the overlay
image imply a co-localization of ACAT1 and AOX (c), analysis
of z-sections showed that they were probably due to the proximity
of some peroxisomes to the large mitochondrial structures and
thus could not be resolved at the light microscopical level.
d–f HepG2 cells were co-transfected with full-length rat ACAT1
containing a myc epitope and pDsRed2-SKL and analyzed after
48 h by direct Xuorescence (e) and immunostaining with antibod-
ies against myc (d) and cytochrome c (f). Note the co-localization
of ACAT1 and cytochrome c, whereas ACAT1 did not co-local-
ize with the punctate peroxisomal pattern for DsRed2-SKL (f).
g–i HepG2 cells were transfected with a construct coding for
DsRed2 containing the C-terminal PTS1 QKL and analyzed after
48 h by direct Xuorescence (h) and immunostaining with an anti-
body against AOX (g). Note the co-localization of DsRed2 end-
ing in QKL, the C-terminus of human ACAT1, and AOX in
peroxisomes, demonstrating the ability of QKL to target to per-
oxisomes (i). Bars 10 m
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due to alternative targeting of the ER enzyme to per-
oxisomes by an as yet uncharacterized mechanism.
Interestingly, Johnson et al. (2003) discovered a novel
isoform of HMGCR by using junction microarrays to
detect alternative splicing. The novel isoform was pres-
ent as a mixture with the known isoform in every
human tissue tested, with the exception of peripheral
leukocytes in which only the novel isoform band was
visible. However, the variant protein cannot catalyze
the reaction of the known isoform, probably because it
lacks a portion of the active site (S. Krisans and W.
Kovacs, unpublished data).
Mevalonate kinase
The N-terminus of MVK contains a consensus PTS2
sequence (Table 1). This PTS2-containing region of
MVK from diVerent organisms is highly conserved
(Petriv et al. 2004). We investigated the subcellular
localization of MVK in HepG2 cells cultured in lipopro-
tein-deWcient medium and in cells overexpressing rat
MVK. We performed immunoXuorescence microscopy
with four diVerent MVK antibodies that have been
shown to be highly speciWc for immunoblot studies
(Biardi et al. 1994). However, only the aYnity-puriWed
polyclonal antibody raised against puriWed MVK pro-
tein obtained from rat liver was suitable for immunoXu-
orescence studies. We were not able to detect any
immunolabeling for MVK in untransfected cells. The
immunoXuorescence pattern obtained with MVK anti-
body in HepG2 cells overexpressing MVK (Fig. 4a) is
superimposable over that for catalase (Fig. 4b, for over-
lay see Fig. 4c). We also co-transfected the plasmid
pJ3-MVK (encoding rat MVK) with pDsRed2-Peroxi
into HepG2 cells. Both MVK (Fig. 4d) and the red Xuo-
rescent peroxisomal protein (Fig. 4e) were co-localized
in peroxisomes (see overlay Fig. 4f).
Phosphomevalonate kinase
Olivier et al. (1999) postulated a predominant peroxi-
somal localization of human PMVK based on expres-
sion studies in CHO cells with two green Xuorescent
protein (GFP) fusion proteins. One fusion protein was
produced by attaching a 600 bp fragment of human
PMVK cDNA, containing the putative PTS1, to the
carboxyl terminus of GFP (pEGFP-PMVK). The other
GFP fusion protein construct was generated similarly;
however, the putative PTS1 sequence SRL was removed
(pEGFP-PMVKPTS). We transfected HepG2 cells
with the same GFP constructs to explore the localiza-
tion of PMVK in human cells. Transient transfection of
pEGFP-PMVK into HepG2 cells resulted in a punc-
tate Xuorescence distribution, indicative of a peroxi-
somal localization (Fig. 5a, d). The punctate pattern of
Fig. 3 Demonstration of peroxisomal localization of HMG-CoA
reductase (HMGCR) in HepG2 cells. The cells were cultured in
medium with 5% LPDS and subjected to double-immunoXuores-
cence using anti-PMP70 followed by Alexa 488-conjugated sec-
ondary antibody (a, d) and monoclonal anti-HMGCR followed
by Alexa 594-conjugated secondary antibody (b, e). Note the co-
localization of PMP70 and HMG-CoA reductase in addition to
the ER labeling of HMG-CoA reductase (c, f). Bars 10 m
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peroxisomal marker enzyme catalase (Fig. 5b) and
PMP70 (Fig. 5e) (see overlays Fig. 5c, f). The putative
PTS1 is required for PMVK localization to the peroxi-
some, since cells transfected with pEGFP-PMVKPTS
showed a diVuse, cytoplasmic Xuorescence (Fig. 5g),
which did not overlap with the Xuorescent punctate
pattern of peroxisomes obtained with antibodies against
catalase (Fig. 5h, for overlay see Fig. 5i) or PMP70
(data not shown).
However, in some transfections with pEGFP-
PMVK or pEGFP-PMVKPTS the GFP-positive cells
displayed a punctate pattern (Fig. 5j) which clearly
diVered from the punctate Xuorescence of PMP70
(Fig. 5k) or catalase (data not shown). The punctate
Xuorescence did not reXect a mitochondrial localiza-
tion, as determined by co-localization studies using the
mitochondrial marker cytochrome c (data not shown);
a lysosomal localization, as determined by co-localiza-
tion studies using the lysosome markers Limp-1 and
Lamp-2 (data not shown); or endosomal localization,
as determined by co-localization studies using antibod-
ies to early endosome antigen 1 (EEA1) and Rab5
(data not shown). Interestingly, these observations are
similar to those published by Hogenboom et al.
(2004b), who observed a punctate pattern that did not
co-localize with the punctate pattern of the peroxi-
somal catalase or the PMP ALDP (adrenoleukodystro-
phy protein). Thus, they reached the conclusion that
this enzyme was not localized to peroxisomes. We
assume that these GFP signals represent aggregates of
misfolded protein due to overexpression, since the
number of cells displaying this punctate pattern
increased with high transfection eYciencies and
increasing DNA amounts.
IPP isomerase
Isopentenyl diphosphate dimethylallyl diphosphate
(IPP) isomerase 1 (IDI1) contains both a putative car-
boxy terminal PTS1 and an amino terminal PTS2
(Table 1; Paton et al. 1997). We investigated the sub-
cellular localization of IDI1 in HepG2 cells cultured in
lipoprotein-depleted medium by immunoXuorescence
microscopy. We performed double labeling using a
highly speciWc aYnity-puriWed polyclonal antibody
directed against mouse IDI1 (Kovacs et al. 2004a)
(Fig. 6a) and a sheep polyclonal antibody against
human catalase (Fig. 6b). The immunoXuorescent
labeling of IDI1 showed a punctate distribution which
was superimposable onto the pattern for the peroxi-
somal marker enzyme catalase (Fig. 6c).
Fig. 4 Demonstration of peroxisomal localization of mevalonate
kinase (MVK) in HepG2 cells. a–c The cells were transfected with
pJ3-MVK (encoding rat mevalonate kinase) and subjected to
double-immunoXuorescence labeling using aYnity-puriWed rab-
bit anti-MVK followed by Alexa 488-conjugated secondary anti-
body (a) and sheep anti-human catalase followed by Texas red-
conjugated secondary antibody (b). d–f HepG2 cells were co-
transfected with pJ3-MVK and pDsRed2-SKL and analyzed af-
ter 48 h by direct Xuorescence (e) and immunostaining with the
aYnity-puriWed rabbit anti-MVK (d). Note the co-localization of
mevalonate kinase with catalase (c) or DsRed2-SKL (f). Nuclear
cross-reactivity of the rabbit anti-MVK was only observed in cells
transfected with pJ3-MVK. Bars 10 m
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human enzyme, expression of full-length hamster IDI1
constructs containing the PTS1 sequence HRM and an
internal HA epitope tag in CHO cells, human control
Wbroblasts and human Wbroblasts deWcient in the PTS2
import pathway resulted in a superimposable punctate
pattern when labeled with anti-catalase and anti-HA
antibodies (Paton et al. 1997), whereas human Wbro-
blasts deWcient in the import of both PTS1 and PTS2
proteins displayed cytosolic labeling when the anti-HA
antibody was used (Paton et al. 1997). Furthermore,
transfection of CHO cells with HA-tagged IDI1 lack-
ing the putative PTS1 HRM sequence revealed a cyto-
solic labeling with the anti-HA antibody (V. Paton,
Fig. 5 Subcellular localization of human EGFP-PMVK and
EGFP-PMVKPTS fusion proteins in HepG2 cells. a–f Tran-
siently transfected pEGFP-PMVK resulted in a punctate distri-
bution of Xuorescence (a, d) which was superimposable on the
immunoXuorescent pattern of the peroxisomal markers catalase
(b) and PMP70 (e). g–i Note the cytosolic green Xuorescence in
HepG2 cells transfected with pEGFP-PMVKPTS (g), whereas
the corresponding catalase distribution remained punctate (h).
j–l In some transfections with pEGFP-PMVKPTS or pEGFP-
PMVK (data not shown) GFP-positive HepG2 cells displayed a
non-organellar punctate Xuorescence (j), which might reXect pro-
tein aggregates. Overlay images (c, f, i, l). Bars 10 m
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284 Histochem Cell Biol (2007) 127:273–290personal communication). These data showed that the
PTS1 sequence is necessary for the targeting of IDI1 to
peroxisomes, and that IDI1 does not use the putative
PTS2 for peroxisomal targeting.
FPP synthase
Indirect immunoXuorescence microscopy studies by
several groups have shown that FPP synthase is local-
ized in the peroxisomes of various cell lines (Krisans
et al. 1994; Olivier et al. 2000; Gupta et al. 1999). How-
ever, subcellular fractionation studies resulted in a sig-
niWcant release of FPP synthase activity into the
cytosolic supernatant (Krisans et al. 1994; Gupta et al.
1999). ImmunoXuorescence studies of myc-tagged rat
FPP synthase demonstrated that FPP synthase utilizes
the PTS2 import pathway and requires a PTS2-like
sequence found within the amino terminal 20 amino
acids for localization (Olivier et al. 2000). In this study,
we investigated the subcellular localization of FPP
synthase in CHO and HepG2 cells by immunoXuo-
rescence microscopy (Fig. 7). ImmunoXuorescence
patterns for FPP synthase and catalase were similar in
CHO-K1 (Fig. 7a–c), PEX2-transfected ZR-82 (ZR-
82/pPEX2) (Fig. 7g–i), PEX2-transfected ZR-87 (ZR-
87/pPEX2) (data not shown), and HepG2 (Fig. 7j–l)
cells. These two enzymes were co-localized in peroxi-
somes as shown by the superimposed images (Fig. 7c, i,
l). In peroxisome-deWcient ZR-82 cells, the punctate
pattern was no longer observed and immunoXuores-
cence for catalase and FPP synthase was evenly distrib-
uted throughout the cytoplasm (Fig. 7d–f). A similar
pattern was observed with peroxisome-deWcient ZR-78
and ZR-87 cells (data not shown). Peroxisome-deW-
cient ZR-78, ZR-82, and ZR-87 cells have mutations in
PEX2, a gene encoding an integral PMP, resulting in
nonfunctional Pex2p. Pex2p is involved in the translo-
cation of peroxisomal matrix proteins following the
docking of PTS receptors to the peroxisome membrane.
When these peroxisome-deWcient CHO cells were
transfected with rat PEX2 and stably selected with
G418, peroxisome assembly was restored as demon-
strated by the punctate Xuorescence pattern obtained
with antibodies to the peroxisomal matrix proteins cat-
alase (Fig. 7h) or AOX (data not shown). Further-
more, the punctate immunoXuorescence pattern for
FPP synthase in PEX2-transfected ZR-82 (ZR-82/
pPEX2) cells (Fig. 7g) coincided with that of catalase
(Fig. 7h, for overlay see Fig. 7i) or AOX (data not
shown), thereby demonstrating the import of FPP syn-
thase into peroxisomes. Taken together, these results
clearly show that FPP synthase is a peroxisomal pro-
tein, similar to the observations reported previously for
various other cell lines.
Digitonin permeabilization studies reveal a similar 
intracellular distribution as immunoXuorescence 
studies
In order to reinforce the data obtained by mass ISA of
cholesterol synthesis and immunoXuorescence micros-
copy, digitonin permeabilization of HepG2 cells and
subsequent western blot analysis was used to further
characterize the subcellular localization of cholesterol
biosynthetic enzymes. Digitonin treatment of cells has
been reported to reversibly permeabilize the plasma
membrane while leaving subcellular organellar mem-
branes intact. Digitonin permeabilizes cells by com-
plexing with cholesterol. Since the membranes of most
cell organelles contain lower levels of cholesterol than
the plasma membrane, cells lose their cytoplasmic
components at lower digitonin concentrations, but the
organellar content remains intact. HepG2 cells were
exposed to increasing concentrations of digitonin. Sub-
sequently, the selective permeabilization and release of
enzymes of cytoplasm or subcellular organelles were
demonstrated with activity measurements or immuno-
blots of distinctive subcellular fractions. The release of
Fig. 6 Demonstration of peroxisomal localization of isopentenyl
diphosphate isomerase (IDI1) in HepG2 cells. a–c HepG2 cells
were incubated in medium with 5% LPDS for 24 h and subjected
to double-immunoXuorescence labeling using rabbit anti-IDI1
followed by Alexa 488-conjugated secondary antibody (a) and
sheep anti-human catalase followed by Texas red-conjugated sec-
ondary antibody (b). The punctated immunoXuorescence pat-
terns of catalase and IDI1 are completely superimposable,
indicating co-localization of the two enzymes in peroxisomes (c).
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ase (PGI), a cytosolic marker, and catalase, a peroxi-
somal marker, were measured (Fig. 8). Most of the
release of cytosolic proteins from the permeabilized
cells occurred at digitonin concentrations of 50 and
150 g/ml. Catalase remained latent (i.e., inside the
peroxisomes) to a digitonin concentration of 150 g/ml.
A release of 50% of the peroxisomal matrix content,
Fig. 7 Demonstration of peroxisomal co-localization of FPP syn-
thase (FPPS) (a, d, g, j) and catalase (b, e, h, k) in CHO and
HepG2 cells. The cells were cultured in medium with 5% LPDS
for 24 h and subjected to double-immunoXuorescence labeling
using aYnity-puriWed rabbit anti-rat FPP synthase followed by
Alexa 488-conjugated secondary antibody and sheep anti-human
catalase followed by Texas red-conjugated secondary antibody.
a–c Wild-type CHO-KI cells. d–f PEX2-defective peroxisome-
deWcient CHO-K1 cells (ZR-82 cells). Note the even distribution
of catalase and FPP synthase throughout the cytoplasm (f). g–i
ZR-82 cells stably transformed with rat PEX2. Note that peroxi-
somes were restored and punctate structures were seen in peroxi-
some-deWcient CHO mutants upon complementation with PEX2
cDNA. j–l HepG2 cells. The punctated immunoXuorescence pat-
terns of catalase and FPP synthase are completely superimpos-
able, indicating co-localization of the two enzymes in
peroxisomes (c, i, l). Bars 10 m
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tion only occurred at much higher concentrations of
digitonin (500–1,000 g/ml). Immunoblot analysis of
the various fractions using the antibodies against IPP
isomerase (IDI1) and MVK revealed a similar distribu-
tion pattern for the IDI1 and MVK proteins as for cat-
alase and AOX, suggestive for the localization of IDI1
and MVK to peroxisomes (Fig. 8). A signiWcant
amount of FPP synthase was released on permeabiliza-
tion as demonstrated by immunoblot analysis of frac-
tions obtained from permeabilized cells (Fig. 8). Our
data are in accordance with Gupta et al. (1999), who
also reported that FPP synthase is not retained after
permeabilization of rat hepatoma cells with digitonin.
However, former immunoXuorescence studies clearly
showed that FPP synthase is localized in peroxisomes
(Fig. 7; Gupta et al. 1999). These data show that perox-
isomal cholesterol biosynthetic enzymes display mark-
edly diVerent association with this organelle.
Discussion
Protein subcellular localization is a key functional
characteristic of proteins. The spatial and temporal
regulation of biochemical reactions in eukaryotic cells
is achieved by a high degree of compartmentation. This
structural diVerentiation facilitates interactions and
yet allows the segregation of diVerent biochemical net-
works. The cholesterol/isoprenoid biosynthetic path-
way has been the subject of extensive studies in the
previous decades due to the panoply of functions of
cholesterol, its metabolites, and its immediate biosyn-
thetic precursors in the proper functioning of cells and
organisms and understanding of cholesterol homeosta-
sis and its Wne regulation is utterly essential. There is
conclusive evidence for the peroxisomal localization of
the pre-squalene segment of the cholesterol biosyn-
thetic pathway in rodents (for review, see Kovacs et al.
2002). However, the role of peroxisomes in cholesterol
biosynthesis in humans has been questioned in recent
reports by Waterham and coworkers (Hogenboom
et al. 2004a, b, c). To resolve the conXicting reports
concerning the localization of enzymes of cholesterol
synthesis, we used immunoXuorescence microscopy,
selective permeabilization techniques, and new stable
isotope labeling techniques and data computations
with ISA.
Our present Wndings obtained by immunoXuores-
cence and selective digitonin permeabilization experi-
ments clearly show that the pre-squalene segment of
the cholesterol biosynthetic pathway is localized to
peroxisomes, which contradicts the results from
Hogenboom et al (2004a, b, c). We obtained further
proof for the localization of the pre-squalene segment
of cholesterol synthesis in peroxisomes by MID analy-
sis of fatty acids and sterols in HepG2 and CHO cells,
since acetyl-CoA derived from peroxisomal -oxida-
tion of very long-chain fatty acids and medium-chain
dicarboxylic acids was preferentially channeled to cho-
lesterol synthesis inside the peroxisomes. In contrast,
fatty acids were not labeled from [1,2,3,4-13C4]docosa-
noate or [U-13C12]dodecanedioate, indicating that ace-
tyl-CoA derived from peroxisomal -oxidation was not
released from peroxisomes and mixing with the cyto-
solic acetyl-CoA transferred from mitochondria before
being used for fatty acid and cholesterol synthesis.
In addition, further proof of the peroxisomal locali-
zation of cholesterol biosynthetic enzymes comes from
studies by Aboushadi et al. (2000) and Weinhofer et al.
(2006). These studies have demonstrated that
HMGCR localized to peroxisomes is more resistant to
inhibition by statins, a class of cholesterol-lowering
drugs, than ER HMGCR. Weinhofer et al. (2006)
Fig. 8 Digitonin permeabilization studies in HepG2 cells.
HepG2 cells were grown in lipoprotein-deWcient medium for 72 h
and afterwards incubated with increasing concentrations of digi-
tonin as described in Materials and methods. Supernatant (open
symbols) and pellet (closed symbols) fractions were analyzed for
the activities of the cytosolic marker phosphoglucose isomerase
(triangle) and the peroxisomal marker catalase (square). The pat-
terns of distribution of the peroxisomal marker proteins catalase
and AOX and the cholesterol biosynthetic enzymes IPP isomer-
ase, mevalonate kinase and FPP synthase were determined by
immunoblot analysis. Equal volumes of each fraction were ana-
lyzed. Note that the distribution pattern for IPP isomerase and
mevalonate kinase was similar to the bona Wde peroxisomal
markers catalase and AOX, whereas FPP synthase was released
on permeabilization
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thesis from [1-14C]acetate and [1-14C]C8:0, but not
from [1-14C]C24:0 as precursor, indicating that
[1-14C]acetyl-CoA units generated by peroxisomal -
oxidation do not leave peroxisomes but rather are used
for cholesterol synthesis.
Furthermore, recent studies by Antonenkov et al.
(2004a, b) indicate that the mammalian peroxisomal
membrane allows free access into the particles only to
small, water-soluble metabolites, while restricting pen-
etration of more bulky organic molecules, such as
cofactors (NAD/H, NADP/H, CoA) and phosphory-
lated substrates. The permeability properties of the
peroxisomal membrane require that the export and
import of redox equivalents into and out of peroxi-
somes, and also the transport of acyl-/acetyl-groups
across the membrane occur via shuttle systems. Peroxi-
somes may possess a separate pool of cofactors that is
functionally independent from the corresponding pool
of cofactors in the surrounding cytoplasm. Since phos-
phorylated products of mevalonate are not able to
cross freely the peroxisomal membrane, it is likely that
the multi-stage conversion of mevalonate to FPP will
take place in one compartment. The export of FPP
across the peroxisomal membrane would be expected
to require peroxisomal membrane transport as has
been shown for other compounds (AMP and ATP)
bearing negatively charged phosphate groups (Palmieri
et al. 2001). Such a peroxisomal transport system for
FPP has not been identiWed yet.
Limitations of the subcellular fractionation approach
may contribute to the discrepancy met with subcellular
localization studies of cholesterol biosynthetic enzymes.
The fragility of peroxisomes under in vitro conditions
is well known and the uncertainty surrounding the
quality of isolated peroxisomes diminishes the validity
of in vitro experiments. Some soluble peroxisomal
matrix proteins are known to easily leak from peroxi-
somes during the isolation of peroxisomes (Alexson
et al. 1985; Antonenkov et al. 2004a, b). Several perox-
isomal oxidases (urate oxidase, L--hydroxyacid oxi-
dase and D-amino acid oxidase) also possess no latency
in digitonin-permeabilized rat hepatocytes, although
this type of treatment is much more protective for per-
oxisomes than tissue homogenization and fractionation
(Verleur and Wanders 1993). This is also exempliWed
by a study from Yoshihara et al. (2001), which clearly
showed by immunolocalization studies that the NADP-
linked isocitrate dehydrogenase 1 (IDH1) is a predom-
inantly, if not exclusively, peroxisomal enzyme in rat
hepatocytes, whereas subcellular fractionation studies
revealed that the enzyme is predominantly cytosolic
and only partially peroxisomal.
It should be noted, that the conXicting data that
have been published recently on the peroxisomal
involvement in the biosynthesis of cholesterol are
based on immunolocalization studies using antisera
against MVK, PMVK, and MPD (Hogenboom et al.
2004a, b, c). It must be pointed out that not all antibod-
ies will work equally well in all assays. Cell staining
techniques place exceptional demands on antibody
speciWcity in order to bind speciWcally to antigens in the
presence of high concentrations of other macromole-
cules. Antibody preparations that are satisfactory for
techniques such as immunoblotting may show spurious
cross-reactions in cell staining. For example, we per-
formed cell-staining experiments with four diVerent
polyclonal antibodies against MVK that have been
shown to be highly speciWc for immunoblot studies
(Biardi et al. 1994); however, only one was suitable for
immunoXuorescence studies. Furthermore, signiWcant
protein levels of cholesterol biosynthetic enzymes in
cells and tissues are only present if the cholesterol bio-
synthetic pathway is induced due to low cholesterol
levels or inhibition by statins. For example, while MVK
was clearly detected in the matrix of peroxisomes in
the liver from cholestyramine plus mevinolin-treated
rats, a treatment that upregulates the cholesterol bio-
synthetic pathway, no immunolabeling was detected in
the livers from control animals (Biardi et al. 1994).
Therefore, great care should be taken with the inter-
pretation of results obtained with immunolocalization
studies of cholesterol biosynthetic enzymes on human
liver sections.
Recently, several computational methods have been
developed with the aim of predicting subcellular and
peroxisomal localization of proteins (Emanuelsson
et al. 2003; Neuberger et al. 2003a, b; Guda and Subr-
amaniam 2005; Xie et al. 2005). The assumption is that
conservation of function and localization is correlated
and thus a prediction of a protein being peroxisomal is
strengthened if also its orthologs in other organisms
are predicted to be peroxisomal. Thus, if localization to
mammalian peroxisomes has been shown in some spe-
cies, orthologs in other organisms are also assumed to
be peroxisomal. For lack of data on PTS2 proteins, in
silico prediction methods focus on proteins carrying
the C-terminal PTS1. The isoprenoid biosynthesis
pathway contains three enzymes with PTS1 motifs
(Table 1). PMVK and IDI1 were predicted to be per-
oxisomal in several organisms using the methods
described by Emanuelsson et al. (2003), Neuberger
et al. (2003a, b), Xie et al. (2005), and Guda and Subr-
amaniam (2005), and their peroxisomal localization
was conWrmed in our study. Furthermore, we also
showed that the C-terminal tripeptide QKL of human123
288 Histochem Cell Biol (2007) 127:273–290ACAT1 is a functional PTS1 signal. One of the limita-
tions of the computational methods is its inability to
accurately predict proteins localized in multiple loca-
tions (e.g., HMGCR, acetoacetyl-CoA thiolase in the
cholesterol biosynthetic pathway). However, several
peroxisomal proteins that have multiple subcellular
localizations have been identiWed, including alanine-
glyoxylate aminotransferase (Oatey et al. 1996; Oda
et al. 2000; Huber et al. 2005), malonyl-CoA decarbox-
ylase (Sacksteder et al. 1999), and -methylacyl-CoA
racemase (Kotti et al. 2000; Amery et al. 2000).
In summary, our results clearly show that the Wrst
part of cholesterol synthesis from acetyl-CoA to FPP
occurs in peroxisomes and refute the hypothesis that
peroxisomes are not involved in the biosynthesis of
isoprenoids and cholesterol. Furthermore, the impor-
tance of peroxisomes for the maintenance of choles-
terol homeostasis in vivo has clearly been
demonstrated in the peroxisome-deWcient PEX2
knockout mouse model (Kovacs et al. 2004a). We are
at present in the process of a more extensive investiga-
tion into the role of acetyl-CoA generated in peroxi-
somes for fatty acid and sterol synthesis. Since it is
diYcult to reconcile the diVerent data regarding the
localization of cholesterol biosynthetic enzymes using
subcellular fractionation and immunohistochemical
techniques, the mass isotopomer distribution analysis
in combination with mathematical modeling provides a
powerful method for metabolic pathway analysis.
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